Bank of New York Mellon Corp
BankPosition in FENC — Fennec Pharmaceuticals Inc.
CIK 1390777
NEW YORK, NY
Position in FENC
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$656,093
+$333,453 QoQ
Shares Held
61,032
+16.3% QoQ
Ownership
0.174%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#30
of 104 holders
Holding Since
Jun 2020
17 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in FENC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Bank of New York Mellon Corp holds $4,845,290,998 across 311 Biotechnology names. FENC ranks #223 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,672,623 | $830,842,010 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
758,492 | $472,950,091 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,578,013 | $380,253,782 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
492,071 | $148,128,128 | |
| 5 | INSM |
INSMED Inc
|
1,312,756 | $139,966,036 | |
| 6 | MRNA |
Moderna, Inc.
|
1,701,675 | $119,168,293 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
601,056 | $112,565,759 | |
| 8 | INCY |
Incyte Corp
|
972,825 | $110,279,435 |
All Filings in FENC
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $656,093 | 61,032 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $322,640 | 52,462 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $378,984 | 49,219 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $489,320 | 52,278 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $430,038 | 51,812 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $325,850 | 53,506 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $329,448 | 52,128 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $258,615 | 51,723 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $419,902 | 68,724 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $535,116 | 48,122 | Shares | Defined | 2024-04-25 | |
| 2023-12-31 | $516,039 | 45,993 | Shares | Defined | 2024-01-29 | |
| 2023-09-30 | $347,951 | 46,332 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $399,485 | 45,242 | Shares | Defined | 2023-08-03 | |
| 2021-03-31 | $278,902 | 44,912 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $341,701 | 45,866 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $294,667 | 48,625 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $404,465 | 48,439 | Shares | Defined | 2020-08-12 | |
| No filing history on record for this holder in this stock. | ||||||